Presentation TCT 2016 High Cost Technologies: How Do You Afford Them? Presenter: Ehtisham Mahmud, Kenneth Rosenfield October 29, 2016
Presentation TCT 2016 Vendor and Industry Relations: The Good, Bad, and Ugly Presenter: Charles E. Chambers, Michael A. Kutcher, Ori Ben-Yehuda October 29, 2016
Presentation TCT 2016 Can Risk-Adjusted Outcomes Differentiate Individual Operator Performance? Presenter: Charles E. Chambers, Michael A. Kutcher, Arnold Seto October 29, 2016
Presentation TCT 2016 SCAI AUC and PCI Risk Apps: How to Make Them Work in Your Lab Presenter: Charles E. Chambers, Michael A. Kutcher October 29, 2016
Presentation TCT 2016 The 10 Most Important Quality Metrics for Your Cath Lab Presenter: Charles E. Chambers, Michael A. Kutcher October 29, 2016
Presentation TCT 2016 Bundle Payment for PCI: Are You Prepared? Presenter: Megan Berlinger, Peter L Duffy, Duane S. Pinto October 29, 2016
Presentation TCT 2016 MACRA and Payment Changes: Are you Ready? Presenter: Megan Berlinger, Peter L Duffy October 29, 2016
Presentation TCT 2016 Cath Lab as a Value Proposition Presenter: Megan Berlinger, Peter L Duffy, Kirk N. Garratt October 29, 2016
Presentation TCT 2016 A Primer of Cath Lab Economics 2016 Presenter: Megan Berlinger, Peter L Duffy, Robert J. Applegate October 29, 2016
Presentation TCT 2016 How to Defuse Interpersonal Conflicts in the Cath Lab Presenter: Robert J. Applegate, Charles E. Chambers, Kirk N. Garratt October 29, 2016
Presentation TCT 2016 Physician and Management Partnerships: Benefits and Challenges Presenter: Robert J. Applegate, Charles E. Chambers, Megan Berlinger October 29, 2016
Presentation TCT 2016 The Role and Responsibilities of the Cath Lab Manager Presenter: Robert J. Applegate, Charles E. Chambers, Bernadette S. Speiser October 29, 2016
Presentation TCT 2016 Effective Strategies for Success of the Medical Director Presenter: Robert J. Applegate, Charles E. Chambers, Ehtisham Mahmud October 29, 2016
Presentation TCT 2016 Welcome and Introduction Presenter: Robert J. Applegate, Charles E. Chambers October 29, 2016
Presentation ISCTR 2016 Requirements for Medical Device Manufacturing and Iteration: FDA Point of Views Presenter: Bradley Quinn October 28, 2016
Presentation ISCTR 2016 Requirements for Medical Device Manufacturing And Iteration Industry Point of View Presenter: Richard Rapoza October 28, 2016
Presentation ISCTR 2016 Challenges and Future Direction for Human Early Feasibility Device Evaluation: Industry Point of View Presenter: David G. Reuter October 28, 2016
Presentation ISCTR 2016 Optimal Pre-Clinical Study Design and Endpoints for Device Evaluation Presenter: Judith A. Davis October 28, 2016
Presentation ISCTR 2016 Current Challenges to and Future Direction of US Early Feasibility Studies FDA Point of View Presenter: Andrew Farb October 28, 2016